The proinflammatory mediators C3a and C5a are essential for liver regeneration

Journal of Experimental Medicine

Volumn 198, Issue 6, 2003, Pages 913-923

  Strey, Christoph W ^a   Markiewski, Maciej ^a   Mastellos, Dimitrios ^a   Tudoran, Ruxandra ^a   Spruce, Lynn A ^a   Greenbaum, Linda E ^a   Lambris, John D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anaphylatoxins; Complement; IL 6; NF B; STAT 3

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; GENE ACTIVATION; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; LIVER REGENERATION; MEDIATOR RELEASE; MORTALITY; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CELL CYCLE; COMPLEMENT C3A; COMPLEMENT C5A; DNA-BINDING PROTEINS; HEPATECTOMY; HEPATOCYTES; INTERLEUKIN-6; LIVER; LIVER REGENERATION; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141449968     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030374     Document Type: Article

References (47)

1. Mastellos, D., and J.D. Lambris. 2002. Complement: more than a 'guard' against invading pathogens? Trends Immunol. 23:485-491.
2. Reca, R., D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L.A. Spruce, A. Janowska-Wieczorek, et al. 2003. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood. 101:3784-3793.
3. Rio-Tsonis, K., P.A. Tsonis, I.K. Zarkadis, A.G. Tsagas, and J.D. Lambris. 1998. Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. J. Immunol. 161:6819-6824.
4. Kimura, Y., M. Madhavan, M.K. Call, W. Santiago, P.A. Tsonis, J.D. Lambris, and K. Rio-Tsonis. 2003. Expression of complement 3 and complement 5 in newt limb and lens regeneration. J. Immunol. 170:2331-2339.
5. Michalopoulos, G.K., and M.C. DeFrances. 1997. Liver regeneration. Science. 276:60-66.
6. Taub, R. 1996. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J. 10:413-427.
7. Diehl, A.M. 2000. Cytokine regulation of liver injury and repair. Immunol. Rev. 174:160-171.
8. Rudnick, D.A., D.H. Perlmutter, and L.J. Muglia. 2001. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc. Natl. Acad. Sci. USA. 98:8885-8890.
9. Fausto, N. 2000. Liver regeneration. J. Hepatol. 32:19-31.
10. Decker, K.F., and M.Y. Obolenskaya. 1995. Cytokines, nitric oxide synthesis and liver regeneration. J. Gastroenterol. Hepatol. 10:S12-S17.
11. Cornell, R.P., B.L. Liljequist, and K.F. Bartizal. 1990. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and tipopolysaccharide-resistant mice. Hepatology. 11:916-922.
12. Gao, C., K. Jokerst, P. Gondipalli, S.R. Cai, S. Kennedy, M.W. Flye, and K.P. Ponder. 1999. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity. Hepatology. 30:1405-1416.
13. Fausto, N. 2001. Liver regeneration. In The Liver, Biology and Pathobiology. M.A. Irwin and J.L. Boyer, editors. Lippincott Williams and Wilkins, New York. 591-610.
14. Mack, C., K. Jungermann, O. Gotze, and H.L. Schieferdecker. 2001. Anaphylatoxin C5a actions in rat liver: synergistic enhancement by C5a of lipopolysaccharide-dependent alpha(2)-macroglobulin gene expression in hepatocytes via IL-6 release from Kupffer cells. J. Immunol. 167:3972-3979.
15. Puschel, G.P., U. Hespeling, M. Oppermann, and P. Dieter. 1993. Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a. Hepatology. 18:1516-1521.
16. Puschel, G.P., M. Oppermann, F. Neuschafer-Rube, O. Gotze, and K. Jungermann. 1991. Differential effects of human anaphylatoxin C3a on glucose output and flow in rat liver during orthograde and retrograde perfusion: the periportal scavenger cell hypothesis. Biochem. Biophys. Res. Commun. 176:1218-1226.
17. Mastellos, D., J.C. Papadimitriou, S. Franchini, P.A. Tsonis, and J.D. Lambris. 2001. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J. Immunol. 166:2479-2486.
18. Higgins, G.M., and R.M. Anderson. 1931. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12:186-202.
19. Aldeguer, X., F. Debonera, A. Shaked, A.M. Krasinkas, A.E. Gelman, X. Que, G.A. Zamir, S. Hiroyasu, K.K. Kovalovich, R. Taub, and K.M. Olthoff. 2002. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology. 35:40-48.
20. Cressman, D.E., R.H. Diamond, and R. Taub. 1995. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology. 21:1443-1449.
21. Kovalovich, K., R.A. DeAngelis, W. Li, E.E. Furth, G. Ciliberto, and R. Taub. 2000. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology. 31:149-159.
22. Crissey, M.A., J.I. Leu, R.A. De Angelis, L.E. Greenbaum, L.M. Scearce, K. Kovalovich, and R. Taub. 1999. Liver-specific and proliferation-induced deoxyribonuclease I hypersensitive sites in the mouse insulin-like growth factor binding protein-1 gene. Hepatology. 30:1187-1197.
23. Sahu, A., A.M. Soulika, D. Morikis, L. Spruce, W.T. Moore, and J.D. Lambris. 2000. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165:2491-2499.
24. Chino, N., S. Kubo, Y. Nishiuchi, S. Kumagaye, K.Y. Kumagaye, M. Takai, T. Kimura, and S. Sakakibara. 1988. Synthesis of porcine C5a anaphylatoxin by the solution procedure and confirmation of the reported structure. Biochem. Biophys. Res. Commun. 151:1285-1292.
25. Fields, G.B., and R.L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
26. Sahu, A., D. Morikis, and J.D. Lambris. 2003. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Mol. Immunol. 39:557-566.
27. Finch, A.M., A.K. Wong, N.J. Paczkowski, S.K. Wadi, DJ. Craik, D.P. Fairlie, and S.M. Taylor. 1999. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42:1965-1974.
28. Morikis, D., and J.D. Lambris. 2001. Structural aspects and design of low-molecular-mass complement inhibitors. Biochem. Soc. Trans. 30:1026-1036.
29. Sahu, A., and J.D. Lambris. 2001. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180:35-48.
30. Frei, Y., J.D. Lambris, and B. Stockinger. 1987. Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies. Mol. Cell. Probes. 1:141-149.
31. Huber-Lang, M., E.M. Younkin, J.V. Sarma, N. Riedemann, S.R. McGuire, K.T. Lu, R. Kunkel, J.G. Younger, F.S. Zetoune, and P.A. Ward. 2002. Generation of C5a by phagocytic cells. Am. J. Pathol. 161:1849-1859.
32. Campbell, W.D., E. Lazoura, N. Okada, and H. Okada. 2002. Inactivation of C3a and C5a octapeptides by carboxy-peptidase R and carboxypeptidase N. Microbiol. Immunol. 46:131-134.
33. Paczkowski, N.J., A.M. Finch, J.B. Whitmore, A.J. Short, A.K. Wong, P.N. Monk, S.A. Cain, D.P. Fairlie, and S.M. Taylor. 1999. Pharmacological characterization of antagonists of the C5a receptor. Br. J. Pharmacol. 128:1461-1466.
34. Cressman, D.E., L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383.
35. Trautwein, C., T. Rakemann, M. Niehof, S. Rose-John, and M.P. Manns. 1996. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology. 110:1854-1862.
36. Yamada, Y., E.M. Webber, I. Kirillova, J.J. Peschon, and N. Fausto. 1998. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology. 28:959-970.
37. Kirillova, I., M. Chaisson, and N. Fausto. 1999. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ. 10:819-828.
38. Hsu, J.C., R. Bravo, and R. Taub. 1992. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol. Cell. Biol. 12:4654-4665.
39. Greenbaum, L.E., W. Li, D.E. Cressman, Y. Peng, G. Ciliberto, V. Poli, and R. Taub. 1998. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 102:996-1007.
40. Hsu, M.H., M. Wang, D.D. Browning, N. Mukaida, and R.D. Ye. 1999. NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood. 93:3241-3249.
41. Yang, M., H. Sang, A. Rahman, D. Wu, A.B. Malik, and R.D. Ye. 2001. G alpha 16 couples chemoattractant receptors to NF-kappa B activation. J. Immunol. 166:6885-6892.
42. Schieferdecker, H.L., G. Schlaf, M. Koleva, O. Gotze, and K. Jungermann. 2000. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6. J. Immunol. 164:5453-5458.
43. Takabayashi, T., E. Vannier, J.F. Burke, R.G. Tompkins, J.A. Gelfand, and B.D. Clark. 1998. Both C3a and C3a (desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. J. Infect. Dis. 177:1622-1628.
44. Takabayashi, T., E. Vannier, B.D. Clark, N.H. Margolis, C.A. Dinarello, J.F. Burke, and J.A. Gelfand. 1996. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol. 156:3455-3460.
45. Fischer, W.H., M.A. Jagels, and T.E. Hugli. 1999. Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg). J Immunol. 162:453-459.
46. Schraufstatter, I.U., K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio. 2002. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. J. Immunol. 169:2102-2110.
47. Kalant, D., S.A. Cain, M. Maslowska, A.D. Sniderman, K. Cianflone, and P.N. Monk. 2003. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acytation-stimulating protein. J. Biol. Chem. 278:11123-11129.